
|Articles|February 19, 2016
Make the Pain Stop: New Shared Platform Eases Investigators’ Burden
Author(s)DIA
Advertisement
TransCelerate BioPharma Inc. CEO Dr. Dalvir Gill shares results of their recent collaboration with the Society for Clinical Research Sites: The Shared Investigator Platform designed to reduce administrative burden by enabling investigative sites to interact with multiple clinical trial sponsors through a single point of access.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Single-Injection, Once-Monthly Maintenance Regimen for Lilly’s Omvoh in Ulcerative Colitis
2
Pharmaceutical Executive Daily: Organon CEO Kevin Ali Resigns
3
GSK Enters $745 Million Worldwide Exclusive License Agreement with Empirico for Clinical-Stage First-In-Class Oligonucleotide Candidate
4
FDA Expands Indication for Merck’s Winrevair in Pulmonary Arterial Hypertension
5





